We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
-10.56%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$273M
AUM Growth
+$47.4M
Cap. Flow
+$32.7M
Cap. Flow %
11.98%
Top 10 Hldgs %
53.37%
Holding
60
New
18
Increased
13
Reduced
8
Closed
18

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.5M
2
CAH icon
Cardinal Health
CAH
+$10.9M
3
LLY icon
Eli Lilly
LLY
+$10.6M
4
SHPG
Shire pic
SHPG
+$10.6M
5
AGN
Allergan plc
AGN
+$10.3M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$25.9M
2
CI icon
Cigna
CI
+$7.15M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$6.51M
4
SNY icon
Sanofi
SNY
+$6.32M
5
ABBV icon
AbbVie
ABBV
+$6.15M

Sector Composition

Rank Sector Weight
1 Healthcare 76.98%
2 Miscellaneous 18.82%
3 Consumer Discretionary 2.55%
4 Industrials 1.65%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
1
PUT
Jazz Pharmaceuticals
JAZZ
$15.9B
$32.3M 11.82%
+247,400
New +$30.8M
QTNT
2
DELISTED
Quotient Limited Ordinary Shares
QTNT
$20.9M 7.64%
59,329
+14,600
+33% +$5.96M
NEOS
3
DELISTED
Neos Therapeutics, Inc
NEOS
$13.9M 5.09%
1,290,023
+508,509
+65% +$5.36M
MCK icon
4
McKesson
MCK
$104B
$13.1M 4.81%
83,600
+27,600
+49% +$4.46M
AMGN icon
5
Amgen
AMGN
$234B
$11.7M 4.26%
+77,721
New +$11.5M
ANTH
6
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$11.1M 4.05%
382,025
+209,720
+122% +$5.69M
CAH icon
7
Cardinal Health
CAH
$54.6B
$11M 4.04%
+134,633
New +$10.9M
SHPG
8
DELISTED
Shire pic
SHPG
$10.9M 3.99%
+63,411
New +$10.6M
JNJ icon
9
PUT
Johnson & Johnson
JNJ
$646B
$10.8M 3.96%
+100,000
New +$10.4M
LLY icon
10
Eli Lilly
LLY
$1.05T
$10.1M 3.7%
+140,392
New +$10.6M
ALNY icon
11
Alnylam Pharmaceuticals
ALNY
$31.7B
$9.65M 3.53%
+153,778
New +$10.2M
AGN
12
DELISTED
Allergan plc
AGN
$9.63M 3.53%
+35,937
New +$10.3M
UTHR icon
13
United Therapeutics
UTHR
$22.1B
$8.62M 3.15%
+77,317
New +$9.78M
SNY icon
14
Sanofi
SNY
$107B
$8.22M 3.01%
204,655
-157,307
-43% -$6.32M
PHG icon
15
Philips
PHG
$26.1B
$8M 2.93%
+391,574
New +$7.23M
DMK
16
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$7.74M 2.83%
18,033
-805
-4% -$288K
VSI
17
DELISTED
Vitamin Shoppe Inc.
VSI
$6.96M 2.55%
224,668
-15,332
-6% -$461K
NVS icon
18
Novartis
NVS
$292B
$6.88M 2.52%
+106,007
New +$7.21M
PFNX
19
DELISTED
Pfenex Inc.
PFNX
$6.52M 2.39%
663,176
+215,914
+48% +$1.89M
AAAP
20
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$6.09M 2.23%
174,001
-117,876
-40% -$3.53M
RXDX
21
DELISTED
Ignyta, Inc.
RXDX
$5.45M 2%
805,327
+160,710
+25% +$1.32M
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
$4.83M 1.77%
413,649
+221,894
+116% +$2.48M
TNET icon
23
TriNet
TNET
$3.23B
$4.5M 1.65%
+313,675
New +$4.45M
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3.73M 1.37%
572,628
+156,656
+38% +$1.01M
FWP
25
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$3.68M 1.35%
30,915
+16,629
+116% +$1.86M
1
2 3

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Sio Capital Management held 60 positions worth $273M, up 21% from $226M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sio Capital Management deployed $32.7M of net new capital in Q1 2016, opening 18 new positions and adding to 13 existing holdings. Its largest new stake was Amgen: 77,721 shares worth $11.7M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 82% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Sanofi, an estimated $6.32M trimmed.

  • Sio Capital Management's largest Q1 2016 buy was Amgen: 77,721 shares worth $11.7M.
  • Sio Capital Management added most to Quotient Limited Ordinary Shares in Q1 2016, an estimated $5.96M increase.
  • Sio Capital Management's biggest Q1 2016 reduction was Sanofi, cutting an estimated $6.32M.
  • Sio Capital Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $25.9M.
  • Sio Capital Management's ten largest holdings make up 53% of its $273M portfolio in Q1 2016.
  • Sio Capital Management opened 18 new positions and closed 18 in Q1 2016.
  • Sio Capital Management's portfolio value rose 21% quarter-over-quarter to $273M.

Based on Sio Capital Management's 13F filing for Q1 2016, filed 16 May 2016.